Mgr. Zbyněk Bortlíček
Researcher, Institute of Biostatistics and Analyses
Correspondence Address:
Kamenice 753/5, 625 00 Brno
E‑mail: |
---|
Total number of publications: 193
2012
-
Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database
Medical Oncology, year: 2012, volume: 29, edition: 5, DOI
-
Pemetrexed in the first line treatment in non-small cell lung cancer (NSCLC): A multicentre prospective analysis of data from cllinical practise of Czech Republic
Year: 2012, type: Conference abstract
-
Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study
Annals of Oncology, year: 2012, volume: 23, edition: 12, DOI
-
Sledování nákladné pneumoonkologické léčby pokročilého nemalobuněčného karcinomu plic (NSCLC) v 1. linii v registru TULUNG v České republice
Farmakoterapie, year: 2012, volume: 8, edition: 5
-
The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer (NSCLC) population of 2365 patients (pts)
Year: 2012, type: Conference abstract
-
The role of a center for tobacco-dependent in cardiovascular prevention. A retrospective study
Neuroendocrinology Letters, year: 2012, volume: 33, edition: S2
-
Účinnost a bezpečnost léčby pemetrexedem a cisplatinou u pokročilého nemalobuněčného karcinomu plic (NSCLC) typu adenokarcinomu a velkobuněčného karcinomu
Studia pneumologica et phthiseologica, year: 2012, volume: 72, edition: 3
-
Use of pemetrexed as first line treatment of advanced non-small cell lung cancer: The Czech Republic experience with the treatment of 237 patients (pts)
Year: 2012, type: Conference abstract
-
Základy moderní pneumoonkologie
Year: 2012, number of pages: 491 s.
2011
-
Alarming data about smoking of Czech adolescents
Year: 2011, type: Conference abstract